Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMab Trial
NCT07563504Phase 4Not yet recruiting
- Sponsor
- Sarawak General Hospital
- Start
- Jul 2026
- Primary completion
- Jan 2027
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 4 trial of gentamicin in premature rupture of membranes (PROM), sponsored by Sarawak General Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
gentamicin
03
Conditions
premature rupture of membranes (PROM)
Beyond the preview
Go deeper on NCT07563504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07563504.